About Rezolute, Inc. 
Rezolute, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 32 Schemes (47.06%)
Foreign Institutions
Held by 45 Foreign Institutions (10.92%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
(Quarterly Results - Dec 2025)
Net Profit:
-23 Million
Pharmaceuticals & Biotechnology
USD 238 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.03
-65.80%
1.86






